Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 1/2015

01.01.2015 | 2014 SSAT Plenary Presentation

Predictors and Outcomes of Readmission for Clostridium difficile in a National Sample of Medicare Beneficiaries

verfasst von: Courtney E. Collins, M. Didem Ayturk, Fred A. Anderson Jr., Heena P. Santry

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Rates of Clostridium difficile (CD) infections are increasing. Elderly patients may be at particular risk of recurrent CD infection. Little is known about the risk for CD readmission specifically in this age group.

Methods

A 5 % random sample of Medicare data (2009–2011) was queried for patients surviving a hospitalization for CD by ICD-9 code. Demographic (age, sex, gender), clinical (Elixhauser index, gastrointestinal comorbidities), and hospitalization (length of stay, ICU admission) characteristics as well as exposure to antibiotics and interim non-CD hospitalization were compared for those with and without a readmission for CD. A multivariable survival analysis was used to determine predictors of readmission.

Results

Of 7,564 patients surviving a CD hospitalization, 8.5 % were readmitted with CD in a median of 25 days (interquartile range (IQR) 14–57). In multivariable survival analyses, interim non-CD hospital exposure was the strongest predictor of CD readmission (hazard ration (HR) 3.75 95 %, confidence interval (CI) 3.2–4.42). Oral and intravenous/intramuscular (IV/IM) antibiotic use, Elixhauser index, and CD as the primary diagnosis also increased the risk of CD readmission. Discharge to hospice, long-term care or a skilled nursing facility decreased the odds of CD readmission.

Conclusion

Hospital exposure and antibiotic use put elderly patients at risk of CD readmission. Exposure to these factors should be minimized in the immediate post discharge period.
Literatur
2.
Zurück zum Zitat Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne. 2004;171 (5):466–72. doi: 10.1503/cmaj.1041104.CrossRef Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne. 2004;171 (5):466–72. doi: 10.1503/cmaj.1041104.CrossRef
3.
Zurück zum Zitat Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2005;40(11):1591–7. doi:10.1086/430315.CrossRef Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2005;40(11):1591–7. doi:10.​1086/​430315.CrossRef
6.
Zurück zum Zitat Khanna S, Pardi DS. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert review of gastroenterology & hepatology. 2010;4(4):409–16. doi:10.1586/egh.10.48.CrossRef Khanna S, Pardi DS. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert review of gastroenterology & hepatology. 2010;4(4):409–16. doi:10.​1586/​egh.​10.​48.CrossRef
7.
Zurück zum Zitat Garborg K, Waagsbo B, Stallemo A, Matre J, Sundoy A. Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scandinavian journal of infectious diseases. 2010;42(11–12):857–61. doi: 10.3109/00365548.2010.499541.PubMedCrossRef Garborg K, Waagsbo B, Stallemo A, Matre J, Sundoy A. Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scandinavian journal of infectious diseases. 2010;42(11–12):857–61. doi: 10.​3109/​00365548.​2010.​499541.PubMedCrossRef
11.
Zurück zum Zitat Eyre DW, Walker AS, Wyllie D, Dingle KE, Griffiths D, Finney J, et al. Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;55 Suppl 2:S77–87. doi:10.1093/cid/cis356.CrossRef Eyre DW, Walker AS, Wyllie D, Dingle KE, Griffiths D, Finney J, et al. Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;55 Suppl 2:S77–87. doi:10.​1093/​cid/​cis356.CrossRef
12.
Zurück zum Zitat Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Medical care. 1998;36(1):8-27.PubMedCrossRef Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Medical care. 1998;36(1):8-27.PubMedCrossRef
13.
Zurück zum Zitat Elixhauser A, Steiner C, Gould C. Readmissions following Hospitalizations with Clostridium difficile Infections, 2009: Statistical Brief #145. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD) 2006. Elixhauser A, Steiner C, Gould C. Readmissions following Hospitalizations with Clostridium difficile Infections, 2009: Statistical Brief #145. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD) 2006.
14.
Zurück zum Zitat McFarland LV, Surawicz CM, Rubin M, Fekety R, Elmer GW, Greenberg RN. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America. 1999;20(1):43–50. doi:10.1086/501553.CrossRef McFarland LV, Surawicz CM, Rubin M, Fekety R, Elmer GW, Greenberg RN. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America. 1999;20(1):43–50. doi:10.​1086/​501553.CrossRef
15.
Zurück zum Zitat Khanna SPD. Clostridium difficile infection; management and strategies for a difficult disease. Therapeutic Advances in Gastroenterology. 2014;7: 72-86. doi:10.1177/1756283X13508519.PubMedCentralPubMedCrossRef Khanna SPD. Clostridium difficile infection; management and strategies for a difficult disease. Therapeutic Advances in Gastroenterology. 2014;7: 72-86. doi:10.1177/1756283X13508519.PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Garey KW, Dao-Tran TK, Jiang ZD, Price MP, Gentry LO, Dupont HL. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics. The Journal of hospital infection. 2008;70(2):142–7. doi:10.1016/j.jhin.2008.06.026.PubMedCrossRef Garey KW, Dao-Tran TK, Jiang ZD, Price MP, Gentry LO, Dupont HL. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics. The Journal of hospital infection. 2008;70(2):142–7. doi:10.​1016/​j.​jhin.​2008.​06.​026.PubMedCrossRef
19.
Zurück zum Zitat Kelly CP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2012; 18 Suppl 6:21–7. doi:10.1111/1469-0691.12046.CrossRef Kelly CP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2012; 18 Suppl 6:21–7. doi:10.​1111/​1469-0691.​12046.CrossRef
21.
Zurück zum Zitat Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne. 2004;171(1):51–8.CrossRef Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne. 2004;171(1):51–8.CrossRef
22.
Zurück zum Zitat Louie TJ, Miller MA, Crook DW, Lentnek A, Bernard L, High KP, et al. Effect of age on treatment outcomes in Clostridium difficile infection. Journal of the American Geriatrics Society. 2013;61(2):222–30. doi:10.1111/jgs.12090.PubMedCrossRef Louie TJ, Miller MA, Crook DW, Lentnek A, Bernard L, High KP, et al. Effect of age on treatment outcomes in Clostridium difficile infection. Journal of the American Geriatrics Society. 2013;61(2):222–30. doi:10.​1111/​jgs.​12090.PubMedCrossRef
24.
Zurück zum Zitat Owens RC. Clostridium difficile-associated disease: changing epidemiology and implications for management. Drugs. 2007; 67(4):487–502.PubMedCrossRef Owens RC. Clostridium difficile-associated disease: changing epidemiology and implications for management. Drugs. 2007; 67(4):487–502.PubMedCrossRef
25.
Zurück zum Zitat Kincaid SE. Clostridium difficile-associated disease: impact of the updated SHEA/IDSA guidelines. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists. 2010;25(12):834–6. doi:10.4140/TCP.n.2010.834.CrossRef Kincaid SE. Clostridium difficile-associated disease: impact of the updated SHEA/IDSA guidelines. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists. 2010;25(12):834–6. doi:10.​4140/​TCP.​n.​2010.​834.CrossRef
26.
Zurück zum Zitat Lucado J, Gould C, Elixhauser A. Clostridium Difficile Infections (CDI) in Hospital Stays, 2009: Statistical Brief #124. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD)2006. Lucado J, Gould C, Elixhauser A. Clostridium Difficile Infections (CDI) in Hospital Stays, 2009: Statistical Brief #124. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD)2006.
27.
Zurück zum Zitat Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonisation and disease. Lancet. 1990;336(8707):97–100.PubMedCrossRef Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonisation and disease. Lancet. 1990;336(8707):97–100.PubMedCrossRef
28.
Zurück zum Zitat Borrego F, Gleckman R. Principles of antibiotic prescribing in the elderly. Drugs & aging. 1997;11(1):7–18.CrossRef Borrego F, Gleckman R. Principles of antibiotic prescribing in the elderly. Drugs & aging. 1997;11(1):7–18.CrossRef
29.
Zurück zum Zitat Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne. 2008;179(8):767–72. doi:10.1503/cmaj.071812.CrossRef Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne. 2008;179(8):767–72. doi:10.​1503/​cmaj.​071812.CrossRef
31.
Zurück zum Zitat Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Annals of internal medicine. 1984;100(2):258-68.PubMedCrossRef Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Annals of internal medicine. 1984;100(2):258-68.PubMedCrossRef
32.
Zurück zum Zitat Commission MPA. A Data Book: Medicare Part D Program. Washington2010 March 2010. Commission MPA. A Data Book: Medicare Part D Program. Washington2010 March 2010.
Metadaten
Titel
Predictors and Outcomes of Readmission for Clostridium difficile in a National Sample of Medicare Beneficiaries
verfasst von
Courtney E. Collins
M. Didem Ayturk
Fred A. Anderson Jr.
Heena P. Santry
Publikationsdatum
01.01.2015
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 1/2015
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-014-2638-6

Weitere Artikel der Ausgabe 1/2015

Journal of Gastrointestinal Surgery 1/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.